Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. The Company operates in two divisions: BioDefense division and BioSciences division. The BioDefense division is directed to government-sponsored development and supply of countermeasures against potential agents of bioterror or bio-warfare and targets the infectious disease, anthrax. Its programs include a pipeline of investigational product candidates and one marketed product, BioThrax (Anthrax Vaccine Adsorbed). The Biosciences division is a specialty pharmaceutical business focused on therapeutics and vaccines in hematology/oncology, transplantation and infectious disease. Its products include WinRho SDF, HepaGam B, VARIZIG and Episil.